Treating cerebral ischemia: Novel therapeutic strategies from experimental stroke research
X Zheng, M Haupt, M Bähr, L Tatenhorst… - Exon …, 2021 - exonpublications.com
Although systemic thrombolysis and endovascular treatment have revolutionized modern
stroke treatment, the majority of patients do not qualify for either treatment paradigm. Hence …
stroke treatment, the majority of patients do not qualify for either treatment paradigm. Hence …
Individual heterogeneity screened umbilical cord-derived mesenchymal stromal cells with high Treg promotion demonstrate improved recovery of mouse liver fibrosis
Y Xie, S Liu, L Wang, H Yang, C Tai, L Ling… - Stem Cell Research & …, 2021 - Springer
Background To investigate the heterogeneities of human umbilical cord mesenchymal
stromal cells (HUCMSCs) derived from different donors and their therapeutic variations …
stromal cells (HUCMSCs) derived from different donors and their therapeutic variations …
Human-derived Treg and MSC combination therapy may augment immunosuppressive potency in vitro, but did not improve blood brain barrier integrity in an …
HW Caplan, KS Prabhakara, NE Toledano Furman… - Plos one, 2021 - journals.plos.org
Traumatic brain injury (TBI) causes both physical disruption of the blood brain barrier (BBB)
and altered immune responses that can lead to significant secondary brain injury and …
and altered immune responses that can lead to significant secondary brain injury and …
Hypoxic Stress Induces Complement-Mediated Lysis of Mesenchymal Stem Cells by Downregulating Factor H and CD59
RR Khaswaneh, E Abu-El-Rub, A Alzu'bi… - Tissue Engineering and …, 2024 - Springer
Background: Factor H and membrane inhibitor of reactive lysis (CD59) are key regulators of
complement activation. Mesenchymal stem cells (MSCs) secrete Factor H and express …
complement activation. Mesenchymal stem cells (MSCs) secrete Factor H and express …
Expediting Molecular Translational Approach of Mesenchymal Stem Cells in COVID-19 Treatment
V Balaji Easwaran, S Satarker… - Current Stem Cell …, 2023 - ingentaconnect.com
Coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) emerged in late 2019 with severe respiratory failure and organ …
coronavirus 2 (SARS-CoV-2) emerged in late 2019 with severe respiratory failure and organ …
Multipotent mesenchymal stromal cell therapy for a neonate with congenital diaphragmatic hernia and adhesive small bowel obstruction
Ş Yıldırım, A Kandırıcı - The Turkish Journal of Pediatrics, 2024 - turkjpediatr.org
Background. In the last decade, therapy using multipotent mesenchymal stromal cells
(MSCs) has offered hope for regenerating the lungs of preterm babies with chronic lung …
(MSCs) has offered hope for regenerating the lungs of preterm babies with chronic lung …
Long-Term in Vivo Monitoring of Transplanted Mesenchymal Stromal Cells in Colitis Mice with Magnetic Particle Imaging
T Shao, Z Gu, Y Liu, X Wang, C Tang, N Chen, M Wang… - papers.ssrn.com
Background: The successful development of mesenchymal stromal cells (MSC)-based
therapeutic strategies in inflammatory bowel disease (IBD) hinges on the ability to assess …
therapeutic strategies in inflammatory bowel disease (IBD) hinges on the ability to assess …